Skytrofa is a prescription growth hormone medication specifically approved for children ages 1 year and older weighing at least 25 pounds who have a diagnosed growth hormone deficiency. This ...

Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...

Skytrofa is administered as a once weekly injection. It comes as a powder in cartridges that you load into an auto-injector device. The dosage of Skytrofa will vary based on your age, weight, and ...

(RTTNews) - Ascendis Pharma A/S (ASND), on Friday, announced that its supplemental Biologics License Application seeking approval of Skytrofa in the proposed treatment of adults with growth hormone ...

Ascendis Pharma's supplemental application for SKYTROFA in adult GHD has been accepted by the FDA, aiming for broader patient access. Acceptance of the sBLA does not guarantee approval; the company ...

Shares of Ascendis Pharma (ASND) did not move much after the company reported positive phase 2 results from the COACH trial that investigated the combination of TransCon CNP and Skytrofa in ...